Proguanil is a medicine used to help prevent malaria. It works by stopping the malaria parasite from growing in your body. It's often taken before you travel to areas where malaria is common, and sometimes while you are there too. It's usually taken with food to help your stomach handle it better.
Every report comes from a Lived member, sent anonymously.
No reports yet
Add what worked for you with the search bar below
Proguanil is an antimalarial medicine. In the United States it is sold only as part of a combination tablet with a second antimalarial, atovaquone, under the brand name Malarone and as generic atovaquone-proguanil. The combination is approved to prevent malaria caused by Plasmodium falciparum, the parasite responsible for most severe and fatal malaria, and to treat uncomplicated malaria of that type. The US Centers for Disease Control and Prevention (CDC) lists it as an option for preventing malaria in travelers to any malaria-endemic area, including places where the parasite has become resistant to the older drug chloroquine. Proguanil was once also taken on its own, sold in the UK as Paludrine, or together with chloroquine. Those products were discontinued in the UK in 2023, so for most people today proguanil means atovaquone-proguanil taken before, during and after a trip.
Malaria parasites live inside red blood cells and, before that, in the liver. To multiply, they must build new DNA, which depends on a supply of building blocks called pyrimidines. The body converts proguanil into cycloguanil, which blocks a parasite enzyme (dihydrofolate reductase) needed for that supply. Atovaquone disrupts a different step, the energy-producing machinery inside the parasite. Attacking two separate pathways at once worked better in trials than either drug alone. The combination acts on the parasite both in the liver and in the blood, which lets it stop parasites at an early stage of infection.
Atovaquone-proguanil is a tablet taken once a day, at about the same time each day, with food or a milky drink. Fat in the meal helps the body absorb atovaquone. Adult tablets contain 250 mg of atovaquone and 100 mg of proguanil; smaller pediatric tablets are dosed by a child's weight. Tablets can be crushed and mixed with condensed milk for someone who cannot swallow them. For prevention, the usual pattern is to start one or two days before arriving in a malaria area, take one tablet daily throughout the stay, and keep taking it for 7 days after leaving. Stopping early is a common reason prevention fails. Treatment of an actual malaria infection uses a higher dose for three days and is directed by a clinician. If you vomit within an hour of a dose, take another dose. If a dose is missed, take it as soon as you remember and then return to the usual schedule, without doubling up. Ongoing vomiting or diarrhea can stop the medicine from being absorbed well enough to protect you, so tell a clinician if it persists.
Most people take atovaquone-proguanil without problems at prevention doses. The effects reported most often are stomach upset, nausea, abdominal pain, diarrhea, headache, mouth ulcers and vivid dreams. In travel studies, it caused fewer stomach problems than chloroquine plus proguanil and fewer sleep and mood effects than mefloquine. The higher doses used to treat malaria are more likely to cause nausea, vomiting, dizziness and loss of appetite. Two uncommon reactions need prompt attention. Serious skin reactions, including Stevens-Johnson syndrome, can start with a rash, blistering or sores in the mouth or eyes: stop the medicine and contact a clinician right away. Liver injury has been reported rarely, including cases needing a transplant. Yellowing of the skin or eyes, dark urine or pale stools should be reported immediately.
Proguanil can strengthen the effect of warfarin (a blood thinner), raising bleeding risk. Anyone taking warfarin should tell the prescriber before starting, so clotting tests (the INR) can be checked when the antimalarial starts and stops. The tuberculosis antibiotics rifampin and rifabutin sharply lower atovaquone levels, and the combination is not recommended. The antibiotic tetracycline and the anti-nausea drug metoclopramide also reduce atovaquone levels. Atovaquone-proguanil is not used for prevention in people with severe kidney disease (creatinine clearance below 30 mL/min, a measure of kidney filtering), because proguanil builds up and can lower blood cell counts. It is not used by anyone who has had a serious allergic or skin reaction to either ingredient. The CDC does not recommend it for malaria prevention during pregnancy because safety data are limited, or for breastfeeding when the infant weighs under 5 kg (11 lb). Other options exist for both situations. It is also not a treatment for severe malaria, which needs hospital care.
Because it is usually well tolerated and only needs to be continued for a week after returning, atovaquone-proguanil is a common choice for short trips. The trade-off is a tablet every single day of the trip. No malaria medicine is fully protective. Insect repellent, long sleeves and bed nets still matter. Malaria symptoms can appear as soon as a week after a mosquito bite or many months after coming home. Fever or a flu-like illness during or after travel to a malaria area needs medical care right away, and the clinician should be told about the trip. If malaria develops despite atovaquone-proguanil, it is treated with a different medicine.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Proguanil, what you've noticed, or ask the community a question.